EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management

Baptiste Cervantes, Clément Grosnon, Thomas Samaille, Leo Mas, Charles Roux, Yves Menu, Jérémie H Lefèvre, Romain Cohen, AndreThierry André

European Journal of Cancer · 2026-01 · 232 · 116119

DOI: 10.1016/j.ejca.2025.116119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-01. Verfasst von Baptiste Cervantes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne University, and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France; Hospital del Mar Research Institute Barcelona, …. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Colorectal Neoplasms, Microsatellite Instability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We aimed to assess patterns of progressive disease (PD) in patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICIs). METHODS: All patients with ICI(s)-treated dMMR/MSI-H mCRC were included in the prospective, single-center ImmunoMSI cohort at Saint-Antoine Hospital and retrospectively analyzed. PD, per iRECIST criteria, was classified as early-global PD (within 6 months), late-global PD (after 6 months), or oligo-PD (limited to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsColorectal NeoplasmsMicrosatellite InstabilityHumansFemaleMaleMiddle AgedAgedDisease ProgressionRetrospective StudiesProspective StudiesAdultAged, 80 and overDNA Mismatch RepairNeoplasm Metastasis

Stichwörter der Autor:innen

Immune checkpoint inhibitorMetastatic colorectal cancerMicrosatellite instability highOligo metastatic progression

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Sorbonne University, and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France; Hospital del Mar Research Institute Barcelona, Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.
  • Sorbonne University, and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France.
  • Sorbonne University, Imaging Department, Hôpital Saint-Antoine, AP-HP, Laboratoire d'Imagerie Biomédicale, UMR 7371, UMR S, Paris 1146, France.
  • Sorbonne University, Digestive Surgery Department, Hôpital Saint-Antoine, AP-HP, Paris, France.
  • Sorbonne University, and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France; INSERM UMRS 938, Équipe Instabilité des Microsatellites et Cancer, Équipe Labellisée par la Ligue Nationale Contre le…

Zitieren

APA

Cervantes, B., Grosnon, C., Samaille, T., Mas, L., Roux, C., Menu, Y., Lefèvre, J. H., Cohen, R., & André, A. (2026). Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management. European Journal of Cancer, 232, 116119. https://doi.org/10.1016/j.ejca.2025.116119

Vancouver

Cervantes B, Grosnon C, Samaille T, Mas L, Roux C, Menu Y, et al. Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management. European Journal of Cancer. 2026;232:116119. doi:10.1016/j.ejca.2025.116119

BibTeX
@article{Cervantes2026,
  author = {Cervantes, Baptiste and Grosnon, Clément and Samaille, Thomas and Mas, Leo and Roux, Charles and Menu, Yves and Lefèvre, Jérémie H and Cohen, Romain and André, AndreThierry},
  title = {Patterns of progressive disease in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer treated with immune checkpoint inhibitor(s): Different entities requiring tailored management},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {232},
  pages = {116119},
  doi = {10.1016/j.ejca.2025.116119}
}
Kostenlos starten →